当前位置:首页 - 行情中心 - 重药控股(000950) - 财务分析 - 现金流量表

重药控股

(000950)

  

流通市值:92.29亿  总市值:92.29亿
流通股本:17.28亿   总股本:17.28亿

现金流量表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金60,978,228,602.638,709,647,952.3517,909,586,501.2573,353,323,258.35
收到的税费返还2,366,280.59668,697.97183,911.817,001,122.39
收到其他与经营活动有关的现金494,329,132.5416,463,161.78242,368,242.471,920,098,828.79
经营活动现金流入的平衡项目0000
经营活动现金流入小计61,474,924,015.6939,126,779,812.118,152,138,655.5275,290,423,209.53
购买商品、接受劳务支付的现金60,469,332,202.1840,496,229,545.5220,132,343,866.6669,102,464,242.61
支付给职工以及为职工支付的现金1,349,189,375.26891,601,578.66486,263,806.961,832,930,062.2
支付的各项税费1,176,871,827.7794,302,551.36370,830,847.611,401,235,086.15
支付其他与经营活动有关的现金1,446,328,977.77761,472,004.29256,424,347.392,667,965,027.02
经营活动现金流出的平衡项目0000
经营活动现金流出小计64,441,722,382.9142,943,605,679.8321,245,862,868.6275,004,594,417.98
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额-2,966,798,367.22-3,816,825,867.73-3,093,724,213.1285,828,791.55
二、投资活动产生的现金流量:
收回投资收到的现金54,977,970.3954,977,970.3954,977,970.39170,158,991.77
取得投资收益收到的现金63,839,276.5359,605,366.53316,140.7647,088,508.69
处置固定资产、无形资产和其他长期资产收回的现金净额3,325,496.642,757,241.948606,592,041.46
处置子公司及其他营业单位收到的现金净额1,865,362.281,865,362.281,865,362.2881,850,216.5
收到的其他与投资活动有关的现金5,725,114.123,593,866.9552,538,272.520
投资活动现金流入的平衡项目0000
投资活动现金流入小计129,733,219.96122,799,808.09109,698,605.95305,689,758.42
购建固定资产、无形资产和其他长期资产支付的现金125,395,372.787,747,302.649,416,121.92268,065,505.09
投资支付的现金-0-2,000,000
取得子公司及其他营业单位支付的现金141,235,046.59138,366,284.890226,863,680
支付其他与投资活动有关的现金74,952,277.6626,141,418.7326,203,469.860
投资活动现金流出的平衡项目0000
投资活动现金流出小计341,582,696.95252,255,006.2275,619,591.78496,929,185.09
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-211,849,476.99-129,455,198.1334,079,014.17-191,239,426.67
三、筹资活动产生的现金流量:
吸收投资收到的现金249,890,143.06244,080,143.0634,576,60015,576,950
其中:子公司吸收少数股东投资收到的现金249,890,143.06244,080,143.0634,576,60015,576,950
取得借款收到的现金20,371,360,775.9513,731,342,089.156,915,075,264.2624,061,066,354.02
收到其他与筹资活动有关的现金491,661,059.74265,275,138.2615,744,458.84677,560,335.57
筹资活动现金流入平衡项目0000
筹资活动现金流入小计21,112,911,978.7514,240,697,370.476,965,396,323.124,754,203,639.59
偿还债务支付的现金17,595,673,689.9610,274,704,887.475,311,743,689.4120,023,277,239.63
分配股利、利润或偿付利息支付的现金1,002,813,226.68561,377,610.92287,274,939.711,067,577,505.13
其中:子公司支付给少数股东的股利、利润83,695,380.1551,145,845.31-138,771,984.02
支付其他与筹资活动有关的现金461,786,140.79268,784,344.2835,527,121.522,483,479,047.87
筹资活动现金流出平衡项目0000
筹资活动现金流出小计19,060,273,057.4311,104,866,842.675,634,545,750.6423,574,333,792.63
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额2,052,638,921.323,135,830,527.81,330,850,572.461,179,869,846.96
四、汇率变动对现金及现金等价物的影响---0
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-1,126,008,922.89-810,450,538.06-1,728,794,626.471,274,459,211.84
加:期初现金及现金等价物余额4,705,207,472.464,705,207,472.464,705,207,472.463,430,748,260.62
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额3,579,198,549.573,894,756,934.42,976,412,845.994,705,207,472.46
补充资料:
净利润-629,081,188.22-1,162,994,521.28
资产减值准备-235,383,243.78-144,442,569.81
固定资产和投资性房地产折旧-102,894,394.07-195,579,686.66
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-102,894,394.07-195,579,686.66
无形资产摊销-15,540,891.67-35,589,870.14
长期待摊费用摊销-23,501,395.7-33,171,871.5
处置固定资产、无形资产和其他长期资产的损失--2,436,571.53--10,048,389.8
固定资产报废损失-0-17,929.21
公允价值变动损失--802,257.06--2,318,026.47
财务费用-642,173,670.06-1,123,389,042.41
投资损失--153,584,150.29--293,349,452.75
递延所得税--36,364,282.4-24,140,326.73
其中:递延所得税资产减少--27,101,305.24-35,565,328.18
递延所得税负债增加--9,262,977.16--11,425,001.45
存货的减少-840,027,026.44--1,823,517,820.56
经营性应收项目的减少--5,287,836,796.69--3,877,960,658.9
经营性应付项目的增加--910,800,784.78-3,400,970,474.79
现金的期末余额-3,894,756,934.4-4,705,207,472.46
减:现金的期初余额-4,705,207,472.46-3,430,748,260.62
公告日期2023-10-272023-08-252023-04-272023-04-27
审计意见(境内)标准无保留意见
TOP↑